本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aclaris Therapeutics

3.60
-0.2300-6.01%
盘前:3.33-0.2700-7.50%05:33 EDT
成交量:342.90万
成交额:1,250.52万
市值:5.30亿
市盈率:-6.14
高:3.84
开:3.80
低:3.59
收:3.83
52周最高:6.60
52周最低:1.74
股本:1.47亿
流通股本:1.01亿
量比:0.51
换手率:3.40%
股息:- -
股息率:- -
每股收益(TTM):-0.5861
每股收益(LYR):-0.5300
净资产收益率:-59.10%
总资产收益率:-28.98%
市净率:4.25
市盈率(LYR):-6.79

数据加载中...

2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/09

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/17

重要事件披露

Form 8-K - Current report
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/07

重要事件披露

Form 8-K - Current report
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]